The effect of early nutritional supplementation with a mixture of probiotic, prebiotic, fiber and micronutrients in infants with acute diarrhea in Indonesia.
A randomized double blind clinical trial was conducted to assess the efficacy of a special infant formula containing Lactobacillus rhamnosus LMG P-22799 (probiotic: 5 x 10(8) CFU/100mL), inulin (prebiotic: 0.15 g/100mL), dietary fiber (soy polysaccharides: 0.2 g/100mL) and increased amounts of zinc+iron (+0.4 and +0.6 mg/100mL, respectively) as active ingredients for the early dietary management of 58 Indonesian well-nourished male infants aged 3-12 months suffering from acute diarrhea with moderate dehydration. After adequate oral rehydration, the patients were randomly assigned to receive either a low lactose infant formula supplemented with added precooked rice (1.5 g/100mL) with the above active ingredients (study group) or a low lactose infant formula with added precooked rice without the above active ingredient supplement (control group). No antibiotic, anti-secretory drug or antiemetic was given at all. Both study and control groups showed similar outcomes for weight gain and stool weight. The duration of diarrhea was significantly shorter in the study group than in the control group (1.63 versus 2.45 days; p<0.05; for the study and control group respectively). No treatment failure or other side effects were observed during the course of the study. The present study supports the evidence for the efficacy of a special anti-diarrhea infant formula containing probiotic, prebiotic, fiber and iron+zinc after oral rehydration by shortening the duration of infantile diarrhea in developing countries. However, from the results of our study we cannot discern the individual contribution of the active ingredients and also not whether they may act independent from each other or in a synergistic way.
Agustina
Rina
R
SEAMEO TROPMED Regional Center for Community Nutrition, University of Indonesia, Campus of UI Salemba, Jl. Salemba Raya no. 6, Jakarta 10430, Indonesia, PO BOX 3852, Jakarta, Indonesia. ragustina@seameo-rccn.org
Lukito
Widjaja
W
Firmansyah
Agus
A
Suhardjo
Hartati Ningsih
HN
Murniati
Dewi
D
Bindels
Jacques
J
D000208:Acute Disease; D003968:Diarrhea, Infantile / Q000188:drug therapy* / Q000453:epidemiology; D004043:Dietary Fiber / Q000008:administration & dosage / Q000627:therapeutic use*; D019587:Dietary Supplements; D004311:Double-Blind Method; D005440:Fluid Therapy; D006801:Humans; D007214:Indonesia / Q000453:epidemiology; D007223:Infant; D007444:Inulin / Q000008:administration & dosage / Q000627:therapeutic use*; D019266:Iron, Dietary / Q000008:administration & dosage / Q000627:therapeutic use; D007778:Lactobacillus / Q000254:growth & development; D008297:Male; D018977:Micronutrients / Q000008:administration & dosage / Q000627:therapeutic use*; D019936:Probiotics / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome; D015430:Weight Gain; D015032:Zinc / Q000008:administration & dosage / Q000627:therapeutic use
D004043:Dietary Fiber; D019266:Iron, Dietary; D018977:Micronutrients; D007444:Inulin; D015032:Zinc